Tourmaline Bio (TRML) Institutional Ownership → Charles Payne’s Gift to Stock Investors (From Unstoppable Prosperity) (Ad) Free TRML Stock Alerts $15.50 -0.18 (-1.15%) (As of 04/29/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Tourmaline Bio (NASDAQ:TRML)CurrentInstitutional OwnershipPercentage91.89%Number ofInstitutional Buyers(last 12 months)10TotalInstitutional Inflows(last 12 months)$98.81MNumber ofInstitutional Sellers(last 12 months)0 Get TRML Insider Trade Alerts Want to know when executives and insiders are buying or selling Tourmaline Bio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data TRML Institutional Buying and Selling by Quarter Ad Unstoppable ProsperityCharles Payne’s Gift to Stock InvestorsRight now, millions of good honest folks are feeling the squeeze. Last year's terrible market did a number on their accounts. Stock values plunged. Retirement accounts lost too.Watch Insider's Advantage Event Tuesday at 4:00 PM ET Tourmaline Bio Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails4/29/2024China Universal Asset Management Co. Ltd.4,939$113K0.0%+109.5%0.019% 4/19/2024 Denali Advisors LLC5,600$128K0.0%N/A0.022% 2/15/2024Great Point Partners LLC672,885$17.62M3.0%N/A3.308% 2/14/2024Braidwell LP906,820$23.74M0.9%N/A4.458% 2/14/2024Avoro Capital Advisors LLC868,407$22.74M0.3%N/A4.269% 2/14/2024RTW Investments LP398,850$10.44M0.2%N/A1.961% 2/13/2024Affinity Asset Advisors LLC68,081$1.78M0.3%N/A0.335% 2/7/2024Jump Financial LLC14,500$380K0.0%N/A0.071% 2/7/2024 Vivo Capital LLC591,882$15.50M1.3%N/A2.910% 1/30/2024 BML Capital Management LLC245,500$6.43M4.9%N/A1.207% (Data available from 1/1/2016 forward) TRML Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of TRML shares? During the previous two years, 10 institutional investors and hedge funds held shares of Tourmaline Bio. The most heavily invested institutionals were Braidwell LP ($23.74M), Avoro Capital Advisors LLC ($22.74M), Great Point Partners LLC ($17.62M), Vivo Capital LLC ($15.50M), RTW Investments LP ($10.44M), BML Capital Management LLC ($6.43M), and Affinity Asset Advisors LLC ($1.78M).Learn more on TRML's institutional investors. What percentage of Tourmaline Bio stock is owned by institutional investors? 91.89% of Tourmaline Bio stock is owned by institutional investors. Learn more on TRML's institutional investor holdings. Which institutional investors have been buying Tourmaline Bio stock? Of the 10 institutional investors that purchased Tourmaline Bio stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Braidwell LP ($906.82K), Avoro Capital Advisors LLC ($868.41K), Great Point Partners LLC ($672.89K), Vivo Capital LLC ($591.88K), RTW Investments LP ($398.85K), BML Capital Management LLC ($245.50K), and Affinity Asset Advisors LLC ($68.08K). How much institutional buying is happening at Tourmaline Bio? Institutional investors have bought a total of 3,775,107 shares in the last 24 months. This purchase volume represents approximately $98.81M in transactions. Related Companies: Replimune Group Major Shareholders Lexeo Therapeutics Major Shareholders Voyager Therapeutics Major Shareholders iTeos Therapeutics Major Shareholders C4 Therapeutics Major Shareholders Adaptive Biotechnologies Major Shareholders Fate Therapeutics Major Shareholders Editas Medicine Major Shareholders Aura Biosciences Major Shareholders Taysha Gene Therapies Major Shareholders This page (NASDAQ:TRML) was last updated on 4/30/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingCharles Payne’s Gift to Stock InvestorsUnstoppable ProsperityHe Is Giving Away BitcoinCrypto Swap ProfitsElon Musk Secret Crypto Plot ExposedCrypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmith4 coins to be the “Next Bitcoin”True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tourmaline Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.